Manufacturing
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Global pharma manufacturing insights: Track supply chain, CMC, regulatory compliance, and innovation trends impacting drug production. Stay ahead.
Showing 1–4 of 4 articles
Trump's Executive Order on Childhood Vaccine Schedules: Impact on Pharmaceutical Companies
President Trump has signed an executive order initiating an overhaul of the childhood vaccine schedule, signaling potential shifts in public health policy. This move could have significant implications for pharmaceutical companies involved in vaccine development and manufacturing.
Emergent BioSolutions Partners with Substipharm for $34.5M Japanese Encephalitis Vaccine Manufacturing Deal
Emergent BioSolutions announces $34.5M partnership with Substipharm Biologics to manufacture IMOJEV Japanese encephalitis vaccine for U.S. government distribution.
FDA Continuous Manufacturing: Key Insights on Drug Quality & Supply Chain
Explore the FDA's continuous manufacturing approach, focusing on improving drug quality and ensuring a resilient supply chain for critical medications like Lipitor.
Bright Path Applauds President's FY2027 Budget for Domestic Pharmaceutical Manufacturing Investment
Bright Path supports President's FY2027 budget proposal investing in advanced pharmaceutical manufacturing technologies to strengthen domestic medicine production capabilities.